Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Cava: Q2 Earnings Snapshot
Cava Group Inc. (CAVA) on Tuesday reported second-quarter profit of $6.5 million, beating Wall Street's expectations.
Load More